Sell Your Veterinary Practice in Ohio in 2026: 5-13x by Tier, PE Platforms, CPVM Structure

Selling your veterinary practice in Ohio in 2026 clears 5-7x EBITDA at the single-DVM lifestyle tier, 7-9.5x at 2-3 DVM general practice scale, 9.5-11.5x at the $1M-$3M EBITDA 4-8 DVM PE platform sweet spot (clean books to 12x), and 11-13x at $3M+ multi-doctor specialty scale. Cleveland, Columbus and Cincinnati density supports platform-quality deals, and Ohio taxes the gain as ordinary income at a flat 2.75% in 2026 (Ohio Department of Taxation), which shapes after-tax proceeds. Active Ohio buyers include Mars Veterinary Health, NVA/Ethos, Mission Pet Health, VetCor, PetVet Care Centers, Heartland and Worthington-based MedVet.

Ohio sits inside one of the busiest consolidation lanes in animal health, and that shapes what your practice is worth. American Economic Liberties Project figures put cumulative private-equity investment in US veterinary at $51.6 billion across 2017-2023, with another $9.3 billion in the first four months of 2024 alone. What makes Ohio a strong seat at that table is geography and a home-state platform: Columbus, Cincinnati and Cleveland each anchor a metro above 2.1 million people (US Census Bureau) strung along I-71 and I-75, and MedVet, the country largest doctor-owned specialty and emergency group, runs its headquarters out of Worthington in the Columbus suburbs. That combination means an Ohio owner is rarely negotiating against a single bidder.

This guide is written for the Ohio DVM who wants to know the price and the path. It walks through 2026 multiples by EBITDA tier, the wellness-plan premium that moves general-practice value most, the named consolidators with clinics already on Ohio ground, and the parts of an Ohio deal that differ from the national template: the Ohio Veterinary Medical Licensing Board (OVMLB) veterinary business facility license under Revised Code Chapter 4741, the fact that Ohio permits corporate ownership of a practice rather than banning it, the Raimonde reasonableness standard that governs whether your non-competes hold, and the Ohio tax picture that decides how much of the check you keep.

CT Acquisitions runs confidential, buy-side processes. No fee to you on buy-side introductions; sell-side mandates are paid on success at closing. For wider context, see our veterinary hub guide, our Private Equity in Veterinary 2026 report, our national guide to selling a veterinary practice, our specialty hospital guide, and our 36-month veterinary practice exit playbook. The free valuation survey takes about three minutes.

How Ohio veterinary practices are valued in 2026, the tiered framework

Ohio veterinary practices are priced off adjusted EBITDA and sorted into size tiers, the same structure buyers apply nationally but read against a genuinely deep Ohio bidder pool. A one-DVM lifestyle or rural mixed-animal clinic under $500K of adjusted EBITDA sits below the threshold where corporate diligence pays for itself, so it usually changes hands between DVMs rather than going to a platform. Move up the tiers and the corridor metros start bidding.

Ohio veterinary practices are priced off adjusted EBITDA and sorted into size tiers, the same structure buyers apply nationally but read against a genuinely deep Ohio bidder pool. A one-DVM lifestyle or rural mixed-animal clinic under $500K of adjusted EBITDA sits below the threshold where corporate diligence pays for itself and typically clears 5x to 7x, changing hands between DVMs or small regional groups rather than going to a platform. A two-to-three-DVM general practice at $500K to $1M of adjusted EBITDA lands in the 7x to 9.5x range, with the top of that band earned by high-margin books that do not lean on one doctor. The four-to-eight-DVM hospital at $1M to $3M is where the corridor platforms compete hardest and clears 9.5x to 11.5x, reaching 12x when the books are clean and a second-tier doctor bench is in place. Above $3M, usually a multi-doctor specialty or referral group, pricing runs 11x to 13x and can stretch to 16x to 18x for a marquee specialty hospital an aggregator wants for geographic fill. Specialty, emergency and 24/7 hospitals carry a 1.5x to 3x premium over general practice. R.L. Hulett Q1 2025 Pet M&A Update reported closed transactions spanning 6x to 16x adjusted EBITDA, and per the American Economic Liberties Project private-equity buyers supplied roughly 80% of 2024 veterinary deal capital. A wellness-plan book above 15% of eligible general-practice cases routinely adds 0.5x to 1.5x on top of the size-tier baseline.

Ohio practice profile	Typical multiple	What moves it in Ohio
Single-DVM lifestyle / rural mixed-animal under $500K EBITDA	5-7x EBITDA	Below the platform diligence floor; sells DVM-to-DVM, common in Appalachian southeast Ohio
2-3 DVM general practice ($500K-$1M EBITDA)	7-9.5x EBITDA	Draws corridor bidders in Columbus and Cincinnati even at modest scale
4-8 DVM hospital ($1M-$3M EBITDA)	9.5-11.5x EBITDA (clean books to 12x)	The tier the I-71 platforms compete for; associate bench and wellness penetration decide the top end
$3M+ EBITDA multi-doctor / specialty / referral	11-13x EBITDA (16-18x for marquee specialty)	MedVet and BluePearl anchor Ohio specialty demand; referral catchment carries it
Multi-site groups (3+ hospitals)	12-15x EBITDA	Regional density across the corridor commands platform-of-platform pricing

The lever that separates a floor multiple from a corridor multiple is competition. A four-doctor Ohio hospital with $1.5M of EBITDA taken quietly to one strategic buyer might settle at 9.5x to 10.5x, roughly $14M to $16M. Placed into a competitive process across the platforms that already operate in Columbus, Cincinnati and Cleveland, that same hospital pulls a second and third bidder to the table, and buyers who mark tuck-ins up on their own balance sheet will pay one to two turns more to win the geography.

How does the wellness-plan / membership premium affect Ohio veterinary practice valuation?

For an Ohio general practice, the wellness-plan book is the single change an owner can make that moves the multiple most. Recurring monthly membership revenue turns transactional cash flow into something a buyer can underwrite as predictable, and every corridor consolidator now expects it.

For an Ohio general practice, the wellness-plan book is the single change an owner can make that moves the multiple most. Practice-management software vendors put plan penetration above 18% of eligible patients across the US, and members spend two to three times what non-plan clients do, so a healthy book converts transactional cash flow into monthly recurring revenue that buyers value more highly because it smooths seasonality, signals retention, and supports a defensible lifetime-value calculation after close. Banfield built the model at scale with its Optimum Wellness Plans, and the groups buying in Ohio, from Mission Pet Health and VetCor to MedVet and Alliance Animal Health, expect an acquired hospital to be on a branded plan within a year to eighteen months. The way to capture the premium in an Ohio process is to stand the plan up 18 to 24 months before you go to market, push penetration past 12 to 15% of eligible general-practice cases, break the recurring revenue out as its own line in the financial pack, and carry it into the quality-of-earnings report as a distinct book. Ohio hospitals that arrive at market with more than 20% penetration and average member tenure past two years regularly clear 75 to 150 basis points above their size-tier baseline. The mirror image is the risk: a purely transactional Ohio practice with thin repeat visits gets marked down in the same diligence.

What do Ohio platform buyers underwrite regarding earnouts and DVM retention?

In Ohio deals, as everywhere in veterinary, the binding constraint a buyer underwrites is doctor retention, not patient demand, so the structure leans on the seller and the associate bench staying put. The corridor buyers pay strong cash at close but hold a slice against clinical continuity.

In Ohio deals, as everywhere in veterinary, the binding constraint a buyer underwrites is doctor retention rather than patient demand, so the structure leans on the seller and the associate bench staying put. A typical Ohio two-to-eight-DVM hospital sold to a platform closes on roughly 70 to 80% cash, with 10 to 20% rolled into equity in a Newco or a platform-level holding company and 5 to 15% held as an earnout keyed to the selling doctor clinical hours through years one to three, associate retention through years one to two, and trailing-twelve EBITDA holding its baseline. Above $5M of enterprise value the rollover slice usually rises to 20 to 30%. The recurring fight is production-comp normalization: many Ohio owners run associate pay at 20 to 25% of production plus distributions, while platforms reset associates to 22 to 24% straight production with no profit share and then recompute adjusted EBITDA on that basis, so agreeing a ProSal floor with the buyer six to twelve months before signing heads off the haircut. The clawbacks have teeth: a typical structure fires if the selling DVM drops under 32 hours a week or under 80% of historical production for any 60-day window in the earnout period, and an associate departure inside 18 months releases part of the escrow back to the buyer. Relief-doctor hours through IndeVets, Roo and similar staffing services generally do not count toward the production thresholds, which matters in a corridor market where relief coverage is easy to lean on.

How much multiple expansion can you achieve through platform-versus-tuck-in arbitrage in Ohio?

The gap between what a platform pays for a single Ohio hospital and what that hospital is worth once it sits inside a larger group is the reason the buyers keep coming back to Columbus, Cincinnati and Cleveland. That spread is where the premium a seller can capture actually lives.

The gap between what a platform pays for a single Ohio hospital and what that hospital is worth once it sits inside a larger group is the reason the buyers keep coming back to Columbus, Cincinnati and Cleveland. A standalone four-doctor Ohio general practice at $1.5M of EBITDA sold direct might clear 9.5x to 10.5x. Tucked into a group that itself trades at a 15x to 18x platform multiple, the same earnings get re-marked at five to seven turns higher on the acquirer books, which is why groups such as Mission Pet Health, VetCor and Alliance Animal Health will pay 11x to 12x for a $1M to $2M Ohio hospital they want. The catch for an Ohio seller is that the premium only shows up when the buyer actually wants your geography or species mix. An off-thesis hospital, wrong corner of the state, wrong case load, or soft earnings quality, gets the floor multiple regardless of how many platforms exist. That is where the corridor helps: because several buyers already operate inside the I-71 triangle, an Ohio owner who runs four to six of them in parallel is far more likely to find the one for whom the practice is on-thesis, and to convert that into one or two extra turns. Tighter acquisition-debt markets through 2024 and 2025 trimmed platform multiples by a turn or two from the 2021-2022 peak, and the late-2025 rate cuts have restarted committed financing, which is part of why Ohio buyers are active again in 2026.

Who is buying Ohio veterinary practices in 2024-2026, named platforms with CURRENT ownership

The Ohio buyer pool is the national buyer pool with several of its members already on the ground here. It splits into Mars permanent capital, roughly 15 private-equity-backed national platforms, and the doctor-controlled alternatives, with MedVet headquartered in Worthington giving Ohio a home-state anchor.

The Ohio buyer pool is the national buyer pool with several of its members already operating inside the state. It splits into Mars permanent capital, roughly 15 private-equity-backed national platforms, and the doctor-controlled alternatives. Mars Veterinary Health is the largest, folding VCA, Banfield and the BluePearl specialty and emergency network under one strategic, permanent-capital umbrella rather than a fund. NVA sits under JAB Holding Company with its Ethos specialty and emergency division, and the 2022 FTC consent order from the SAGE deal still restricts JAB specialty and ER acquisitions within 25 miles of an existing JAB clinic in California and Texas. Mission Pet Health, backed by Shore Capital Partners, reached roughly 750 clinics after the July 2025 merger of Mission Veterinary Partners and Southern Veterinary Partners. VetCor is led by Oak Hill Capital with Harvest Partners and Cressey & Co. and has been among the most active general-practice tuck-in buyers. PetVet Care Centers has been owned by KKR since 2022 (not Onex) and, per the CT Acquisitions Ohio buyer ledger, already runs hospitals in Cincinnati, Springfield and Toledo. Heartland Veterinary Partners is now Gryphon Investors majority after its 2024-2025 recap (not American Securities); AmeriVet is held by AEA Investors and the Abu Dhabi Investment Authority since the February 2022 recap (not Imperial Capital) and, per the same ledger, operates in Cincinnati, Columbus, Grove City, Portsmouth and Wooster under the Alliance Animal Health banner. Other national platforms in the pool include Veterinary Practice Partners (Audax), Innovetive Petcare (Metalmark), United Veterinary Care (Nordic Capital, not Atlantic Street), Suveto (Levine Leichtman, not LongueVue), Veritas (Percheron), Encore Vet Group (North Castle), Rarebreed (Revelstoke), Bond Vet (Warburg Pincus urgent care), VetEvolve (Varsity Healthcare) and Thrive Pet Healthcare (TSG Consumer). Pieper Veterinary is backed by Chicago Pacific Founders, the same sponsor behind COVE Animal Health, which per the ledger operates in North Ridgeville west of Cleveland. Heart + Paw has an integrated-care location in Cincinnati. The doctor-controlled route is real in Ohio too: MedVet is roughly 95% DVM and employee owned with a Leonard Green minority and Oak Hill Advisors debt, is headquartered in Worthington, and per the ledger runs Ohio hospitals in Worthington, New Albany, Hilliard, Canal Winchester, Cleveland, Fairfax in Cincinnati and West Chester, and Galaxy Vets is the first US consolidator built as an employee stock ownership plan.

How are different veterinary sub-verticals valued in Ohio?

Buyers rank Ohio veterinary sub-verticals on a clear hierarchy. General practice is the backbone of the platform thesis; specialty and referral sit at the top of the multiple range, and MedVet home-state presence gives Ohio unusually strong specialty demand.

Buyers rank Ohio veterinary sub-verticals on a clear hierarchy. General practice is the backbone of the platform thesis at 5x to 12x adjusted EBITDA by size, with buyers favoring two-to-eight-DVM hospitals that carry a stable associate bench, own or control their real estate, and run a wellness book. Specialty and referral practices, covering surgery, internal medicine, oncology, cardiology, neurology, dermatology and ophthalmology, trade highest at 11x to 14x and up to 16x to 18x for a marquee multi-specialist hospital with strong referral catchment. Ohio is unusually well served here because MedVet is headquartered in Worthington and BluePearl under Mars competes for the same referral cases, so an Ohio specialty seller faces real bidding rather than a thin market. Emergency, urgent-care and 24/7 hospitals carry 11x to 13x on the scarcity of overnight staffing and the specialty cross-sell, with MedVet, BluePearl, Bond Vet and Pieper leading that lane. Mixed-animal, equine and food-animal practices, more common in Ohio rural west and southeast, are a separate buyer pool at 5x to 8x, since production-animal economics, travel logistics and USDA APHIS oversight do not standardize well at platform level and the buyers tend to be other large-animal DVMs or regional groups. Mobile and house-call practices are capital-light but doctor-time-bound with little platform appetite because there is no real-estate moat. Multi-site groups of three or more hospitals are the single most attractive Ohio archetype, since the corridor gives buyers regional density and a pipeline of further tuck-ins, and they pay platform-of-platform multiples of 12x to 15x for it.

Our national data on veterinary practice valuation multiples shows what buyers actually pay by tier.

What is the Ohio veterinary market context in 2026?

Ohio permits corporate ownership of a veterinary practice rather than banning it, and MedVet, headquartered in Worthington, is both the dominant specialty group in the state and the largest doctor-owned specialty consolidator in the country. Platform activity concentrates in Columbus, Cincinnati and Cleveland.

Ohio permits corporate ownership of a veterinary practice rather than banning it, which is the first thing that separates it from restricted states like New York or Texas. The Ohio Veterinary Medical Association moved years ago to rescind its old prohibition on non-DVM ownership, and the Ohio Veterinary Medical Licensing Board settled its long dispute with VCA by allowing corporate operation as long as a veterinarian holds legal ownership of the practice entity. In practice, the state regulates the clinic through a veterinary business facility license under Revised Code Chapter 4741, not through a corporate practice ban, so most Ohio deals proceed without the friendly-PC-plus-management-company scaffolding that restricted states require. Demand concentrates where the people and the doctors are. MedVet home base in Worthington and its cluster of Columbus-area hospitals make central Ohio the deepest specialty market in the state, and Ohio State College of Veterinary Medicine in Columbus, graduating roughly 165 DVMs a year, feeds an in-state associate pipeline that lowers the staffing risk buyers weigh most heavily near the metros. Columbus is a genuine population-growth engine while northeast Ohio runs closer to flat, so buyers price the central corridor more aggressively than the rust-belt edge, and the Appalachian southeast stays the thinnest part of the map.

Which buyers are actually near your Ohio practice, and what your location does to your negotiating position

Ohio is one of the strongest platform-buyer states in the Midwest, and the reason is geographic: three large MSAs (Columbus, Cincinnati, Cleveland) each over 2.1M people sit within roughly one to two hours of each other along and around the I-71 / I-75 corridors, and MedVet the specialty/ER consolidator is headquartered in Worthington (Columbus metro). A seller almost anywhere in the populated western and central band of Ohio has multiple confirmed platforms either in-metro or within a 2-hour drive, which means real bidder competition rather than a single take-it-or-leave-it offer.

• Columbus: MedVet (HQ Worthington + New Albany, Hilliard, Canal Winchester/Diley Hill hospitals); Alliance Animal Health (Columbus + Grove City). Deepest bidder bench in the state and MedVet’s home turf.
• Cincinnati: MedVet (Fairfax + West Chester); Alliance Animal Health (Cincinnati); PetVet Care Centers (Cincinnati); Heart + Paw (Cincinnati). The densest confirmed platform cluster in Ohio: four distinct platform types (specialty/ER, JV/DSO, KKR-backed GP, integrated-care) are already in-metro, plus cross-border reach into Kentucky.
• Cleveland: MedVet (Cleveland); COVE Animal Health (North Ridgeville, western Cleveland suburb). Two confirmed in-metro platforms (MedVet, COVE) plus Alliance at Wooster within an hour.
• Dayton: PetVet Care Centers (Springfield, just NE of Dayton). The clearest example of the drive-time rule working in a seller’s favor.
• Toledo: PetVet Care Centers (Toledo). One confirmed in-metro platform (PetVet).
• Akron / Canton: no confirmed in-market platform. No confirmed in-metro platform, but functionally a suburb of the Cleveland buyer pool.
• Southeast / Appalachian Ohio (Portsmouth, Athens, rural SE): Alliance Animal Health (Portsmouth), notable outlier confirming Alliance reaches into southern Ohio. The genuinely platform-thin part of Ohio.

Ohio’s distinguishing feature is the I-71 metro triangle plus MedVet’s in-state HQ: the western and central two-thirds of the state is genuinely platform-rich in reach, and even mid-size markets like Dayton borrow big-metro bidder competition through short drive times. The eastern/southeastern Appalachian band is the thin exception.

Your location scored on five factors

Proximity to an existing platform is the hook, but it only converts if you clear the size bar, and three more factors, metro depth, DVM labor supply, and the demand trend, decide how hard buyers actually compete. Here is how Ohio reads on all five.

Factor	What it means for your exit
Buyers near you	Confirmed platforms sit in-metro across Columbus, Cincinnati, and Cleveland, and MedVet is HQ’d in Worthington, so the I-71 triangle puts most western and central sellers within 2 hours of at least two platforms.
Your size gate	In Columbus/Cincinnati even a single- or two-DVM practice can draw institutional interest, but off the corridor the scale bar climbs, and in Appalachian SE Ohio a buyer needs meaningfully higher revenue/EBITDA and transferable doctor production to justify the distance.
Metro depth	Three large MSAs over 2.1M (Columbus, Cincinnati, Cleveland) plus Dayton borrowing their benches by drive time give real auction depth across the populated two-thirds of the state.
DVM labor supply	Ohio State’s vet college in Columbus (~165 seats, growing toward 200) feeds a steady in-state associate pool that lowers staffing risk near the metros; rural SE Ohio stays thin.
Demand trend	Columbus is a genuine growth engine (~1.38% YoY, immigration-driven), Cincinnati grows modestly, but NE Ohio is near-flat (~0.26%) and Appalachia declines, so demand is bifurcated.

Start with the hook: a confirmed platform is very likely already close to you. Three metros over two million people (Columbus, Cincinnati, Cleveland) sit within a one-to-two-hour drive along I-71, and MedVet is headquartered in Worthington, so much of the western and central state has multiple platforms in reach. But proximity only converts if you clear the size bar. In Columbus and Cincinnati that bar is low enough that even a single- or two-DVM practice can draw a real institutional bid; move off the corridor into Appalachian southeast Ohio and a buyer needs meaningfully more revenue, EBITDA, and transferable doctor production before nearby platforms engage, so a sub-scale practice there is really looking at a local or individual buyer, not an auction.

MSA depth reinforces the picture. Three large MSAs give genuine bidder benches, and Dayton borrows big-metro competition through short drive times, so auction tension is real where the metros are, thin where they are not. Labor is a tailwind near the pipeline: Ohio State’s veterinary college in Columbus feeds a steady associate supply that lowers the staffing risk buyers fear most and supports higher multiples, though that relief does not travel to rural counties. Demand is the honest caveat, not a headwind but not uniform: Columbus is a real growth engine, Cincinnati grows modestly, but northeast Ohio is near-flat and Appalachia is shrinking, so buyers price central Ohio more aggressively than the rust-belt edge.

Underneath all of it, the rules are clean: non-vets can own outright through a facility license, non-competes hold under Ohio’s reasonableness test, and the state tax on your gain drops to a flat 2.75 percent in 2026. Position on the corridor, your scale, staffing depth, and clean books are what combine into your price.

What should Ohio veterinary sellers know about the ownership rules, facility licenses, and FTC scrutiny?

Selling an Ohio veterinary practice touches three regulatory layers, but the first one is friendlier here than the national template assumes: Ohio does not bar non-veterinarian ownership. The layers are the OVMLB veterinary business facility license, federal DEA registration, and the antitrust backdrop.

Selling an Ohio veterinary practice touches three regulatory layers, and the first is friendlier here than the national template assumes. Many states restrict or prohibit non-veterinarian ownership and force private-equity buyers into a management-services-organization structure where a friendly DVM holds the practice while a company owned by the sponsor provides administration under a long-term services agreement. Ohio is not one of those states. The Ohio Veterinary Medical Licensing Board resolved its dispute with VCA by permitting corporate operation of a practice provided a veterinarian holds legal ownership, and the state regulates the clinic itself through a veterinary business facility license under Revised Code Chapter 4741 rather than through an ownership ban. That means most Ohio buyers can hold the practice more directly and can usually avoid the $50K to $150K of extra structuring cost that a restricted-state friendly-PC arrangement adds. What Ohio does require is attention to the facility license: no one may operate a veterinary business facility without a valid license naming the owning or controlling entity, and under the board administrative rules (Ohio Administrative Code 4741-2-02) the OVMLB must be notified within 30 days of a change in ownership, so the license update belongs on the closing checklist. The second layer is federal and unchanged by state law: each location that stores or dispenses controlled substances needs its own DEA registration, the new owner obtains a fresh DEA number, the controlled-substance inventory transfers with a documented count signed by both sides at close, and Schedule II drugs move on DEA Form 222. The third layer is antitrust posture. The 2020 NVA / Compassion-First and 2022 JAB / SAGE FTC consent orders remain in force, the May 2024 FTC and DOJ request for information named veterinary roll-ups as a concern, and a January 2025 FTC settlement signaled that stealth sub-HSR acquisitions in fragmented healthcare verticals are on the agenda, so a deal where the likely Ohio buyer already owns nearby specialty or ER capacity can draw a longer review.

How this applies to an Ohio veterinary practice sale

For an Ohio seller the sequence is shorter than in a restricted state. First, ownership: because Ohio allows corporate operation with a DVM as legal owner, the deal usually does not need a friendly-PC-plus-management-company workaround, which removes a cost and a delay that New York, Texas or Illinois sellers cannot avoid. Second, the facility license: the practice keeps its veterinary business facility license under Revised Code Chapter 4741 current and notifies the OVMLB of the ownership change within the 30-day window set by the board rules. Third, DEA: the new owner secures a fresh DEA registration, the controlled-substance inventory transfers with a signed count, and Schedule II items move on Form 222, with the Ohio Board of Pharmacy terminal-distributor license updated in parallel. Fourth, antitrust: if the most likely platform bidder already holds specialty or emergency capacity near you, in the Columbus or Cincinnati clusters especially, build extra review time into the calendar. Plan on roughly 90 to 150 days from signing to close, with the DEA reissuance and, in specialty-dense pockets, any FTC look as the constraints that actually set the pace.

What deal mechanics are specific to Ohio veterinary practice sales?

The deal mechanics on an Ohio veterinary sale follow the national pattern with two Ohio-specific bends: non-compete enforceability runs on the Raimonde reasonableness test rather than a bright-line rule, and the ownership-transfer step is a facility-license notification rather than a corporate-practice workaround.

The deal mechanics on an Ohio veterinary sale follow the national pattern with a couple of Ohio-specific bends. Rollover equity typically runs 20 to 30% of proceeds into a Newco or platform holding company on deals above $5M of enterprise value, vesting over three to five years and monetizing at the next recap on a four-to-six-year hold. The DVM-retention earnout holds 5 to 15% of consideration against the seller continued clinical hours, associate retention through years one to two, and EBITDA stability, with a clawback if the seller falls under 32 hours a week or under 80% of pre-close production for any 60-day window. Production-comp normalization is the same recut buyers apply everywhere: associates reset to 22 to 24% straight production and adjusted EBITDA is recomputed on that basis, which can trim it 5 to 15% unless the seller pre-empts it. The first Ohio-specific point is non-competes. Ohio does not follow a bright-line ban; it applies the reasonableness test from the Ohio Supreme Court decision in Raimonde v. Van Vlerah (1975), which upholds a restriction that protects a legitimate business interest, does not impose undue hardship on the doctor, and does not harm the public, and Ohio courts will reform an overbroad covenant rather than void it outright. Sale-of-business non-competes given by a selling owner are the strongest kind and generally hold; associate non-competes are judged on the same reasonableness factors, and owners should note that Senate Bill 11, introduced in 2026, proposes to curtail employee non-competes, so this is an area to confirm with Ohio counsel at signing. The second Ohio-specific point is the ownership transfer itself: instead of restructuring around a corporate-practice ban, the parties keep the veterinary business facility license current and notify the OVMLB of the change within 30 days. Real estate is commonly split into a separate entity at signing and leased back on a 15-to-20-year triple-net lease, leaving veterinary real estate as independent optionality at roughly 5.5% to 7.5% cap rates.

Why is the DVM succession crisis driving Ohio veterinary owners to sell now?

The engine behind the Ohio selling wave is succession, not a doctor shortage. The AAVMC projects enough new graduates to meet aggregate demand, so the real driver is an aging pool of practice owners deciding to step back, and Ohio has a large cohort reaching that decision now.

The engine behind the Ohio selling wave is succession, not a doctor shortage. The 2025 AVMA Report on the Economic State of the Veterinary Profession counts roughly 130,415 DVMs in the US workforce, most in small-animal practice, and the AAVMC 2024 supply-and-demand study concluded that new graduates from existing colleges should meet aggregate demand through the mid-2030s, with real shortfalls concentrated in rural, food-animal and emergency staffing rather than across the board. The more durable driver is demographic. Peer-reviewed survey work published in JAVMA over 2024 and 2025 found that 61% of clinical-practice DVMs intend to cut clinical hours within five years and 31% intend to stop clinical work entirely, and roughly 8% of working veterinarians are already 66 or older. Ohio feels this on two sides at once: its metro practices sit near a steady Ohio State graduate pipeline that keeps associate supply healthier than in thinner states, while its large base of owner-operators who built practices in the 1980s and 1990s is now reaching retirement. With private-equity capital restarted by the late-2025 rate cuts and buyers already positioned along the I-71 corridor, 2026 through 2030 is the structural window when more Ohio owners cross 60 than at any prior point.

Why an Ohio veterinary practice sale needs vertical-specific advice

A generalist advisor who treats an Ohio veterinary practice as any other services business will miss the levers that move the price and will misread the Ohio rules, most importantly by assuming a corporate-practice ban that Ohio does not have.

A generalist advisor who treats an Ohio veterinary practice as any other services business will miss the levers that move the price and will misread the local rules. The wellness-plan documentation, the rollover-equity slice that monetizes at the next recap, the 5 to 15% production-comp recut buyers apply to pre-close numbers, the 32-hour and 80%-production earnout thresholds, and the split between enforceable sale-of-business non-competes and more contestable associate covenants are all veterinary-specific diligence items. Two of them are Ohio-specific. The first is that Ohio permits corporate ownership through a facility license, so an advisor who reflexively builds a friendly-PC-plus-management-company structure adds cost and delay the deal does not need. The second is that Ohio non-competes turn on the Raimonde reasonableness test rather than a bright-line rule, which changes how you draft and how you value doctor retention. An Ohio seller working with someone who knows the current platform cap tables, which buyers already sit in the corridor, and how Ohio actually licenses and enforces, negotiates as an equal rather than being educated by the buyer diligence team at their own expense.

What is the 18-24 month pre-sale playbook for Ohio veterinary practices?

Ohio owners who reach the top of their tier prepare deliberately over 12 to 24 months. The priorities are the wellness book, a real associate bench, clean normalized earnings, a current facility license, and using the corridor to run a genuine competitive process.

Ohio owners who reach the top of their tier almost always prepared deliberately. With 12 to 24 months of runway, work down this list:

• Stand up a wellness plan 18 to 24 months out. Push penetration past 12 to 15% of eligible cases, break recurring revenue out in the financials, and carry it into the quality-of-earnings report; in an Ohio process this one move can add 75 to 150 basis points over the size-tier baseline.
• Move associates to ProSal six to twelve months before signing. Pre-empting the platform production-comp reset neutralizes the 5 to 15% EBITDA haircut buyers otherwise apply.
• Build the associate bench. A single-DVM practice sits below the platform floor; getting to two or three doctors reaches 7x to 9.5x and four to eight reaches the 9.5x to 11.5x tier, and near Columbus the Ohio State pipeline makes hiring that bench realistic.
• Normalize owner compensation. Set owner W-2 and production at market and let the excess fall to EBITDA, documented in payroll and K-1 detail before diligence starts.
• Keep the facility license and DEA clean. A current veterinary business facility license under Revised Code Chapter 4741, a clean OVMLB record, and an accurate Schedule II inventory are table stakes in Ohio diligence.
• Draft non-competes to the Raimonde standard. Reasonable time and geography that protect a legitimate interest without undue hardship are far more likely to survive an Ohio court than an overbroad covenant, and they reassure the buyer on doctor retention.
• Decide on the real estate. Carving the building into a separate entity and leasing it back on a long triple-net at market rent creates independent optionality at roughly 5.5% to 7.5% cap rates.
• Use the corridor. Because several platforms already operate inside the I-71 triangle, run four to six of them in parallel rather than taking the first inbound offer; competition is what converts proximity into price.

For the broader framework, see our Private Equity in Veterinary 2026 report, our 36-month veterinary exit playbook, and the lower middle market buyer mandate report.

What are the most common mistakes Ohio veterinary practice owners make when selling?

The mistakes that cost Ohio sellers money cluster around anchoring on revenue, missing the production-comp recut, chasing outdated buyer lists, and taking the first offer when the corridor gives them a real auction.

• Anchoring on revenue instead of adjusted EBITDA, doctor-retention structure and wellness-plan penetration, which are what buyers actually pay for.
• Not modeling the production-comp recut. Platforms reset associates to 22 to 24% straight production and recompute EBITDA, a 5 to 15% cut that is routine unless you pre-empt it.
• Working an outdated buyer list. PetVet is KKR (not Onex), Heartland is Gryphon (not American Securities), AmeriVet is AEA and ADIA (not Imperial Capital), United Veterinary Care is Nordic Capital (not Atlantic Street), and Suveto is Levine Leichtman (not LongueVue); outreach to stale cap tables wastes runway.
• Assuming Ohio bans corporate ownership. It does not, and building a friendly-PC-plus-management-company structure the deal does not need adds cost and delay rather than protection.
• Drafting non-competes that ignore Raimonde. An overbroad covenant invites an Ohio court to narrow or reject it; a reasonable one protects the buyer and holds up.
• Overlooking the doctor-controlled route. MedVet, headquartered in Worthington and roughly 95% DVM and employee owned, and Galaxy Vets, built as an ESOP, are genuine Ohio-accessible options for owners who want liquidity without handing clinical control to a fund.
• Taking the first inbound offer. With multiple platforms inside the I-71 triangle, a confidential competitive process typically lifts terms by one to two turns of EBITDA over a single-bidder negotiation.

Sell Your Veterinary Practice: Ohio and beyond

Companion guides for Ohio sellers:

• Sell Your Veterinary Practice / Animal Hospital (national overview)
• Private Equity in Veterinary 2026: Active Platforms, Multiples, and Consolidation
• How to Sell a Veterinary Practice 2026
• Selling a Veterinary Specialty Hospital in 2026
• How to Prepare Your Veterinary Practice for a Sale or Exit (2026)
• How to Buy a Veterinary Practice in 2026 (Buyer’s Playbook)
• The lower middle market buyer mandate report
• Exit multiple: the 2026 operator’s guide

Ohio veterinary practice sale: 2026 outlook and key takeaways

Veterinary is one of the deepest consolidation pools in healthcare-adjacent services, and Ohio is a strong seat in it. Cumulative private-equity investment reached $51.6 billion over 2017-2023 with another $9.3 billion in early 2024 (American Economic Liberties Project), 15-plus national platforms compete alongside Mars permanent capital, and a structural seller wave is building as 61% of clinical-practice DVMs plan to cut clinical hours within five years (JAVMA 2024-2025). An Ohio hospital with four to eight doctors, wellness penetration past 12 to 15%, normalized production comp, a current veterinary business facility license and DEA registration, clean real-estate optionality, and non-competes drafted to the Raimonde standard can realistically reach the upper end of its 9.5x to 11.5x tier, with multi-site groups reaching 12x to 15x. The things that most often cost Ohio sellers money are an unprepared production-comp recut, outreach to stale buyer lists, drafting around a corporate-practice ban Ohio does not have, ignoring the antitrust look in specialty-dense metros, and accepting the first offer instead of running the corridor as the competitive process it can be.

This guide reflects 2026 veterinary M&A conditions and CT Acquisitions direct work with active acquirers. Multiples are directional, not a guarantee; every practice is underwritten on its own doctor roster, wellness-plan penetration, adjusted EBITDA, real-estate optionality and growth profile. Ohio veterinary business facility licensing under Revised Code Chapter 4741, OVMLB ownership-change notification rules, DEA registration transfer, Ohio non-compete standards under Raimonde v. Van Vlerah and pending Senate Bill 11, the 2022 FTC JAB / SAGE consent order, the May 2024 FTC / DOJ serial-acquisitions RFI, and Ohio tax provisions are all subject to change; confirm current requirements with qualified Ohio veterinary counsel before relying on them in a transaction.

Related sale guides for Ohio sellers

If you operate a different business in Ohio, our state-specific sub-guides walk through the named PE buyers, current valuation multiples, and Ohio-specific deal mechanics for each vertical. You can also explore veterinary practice sales in other high-activity states.

Other Ohio industry sale guides

• Sell a CPA / accounting firm in Ohio
• Sell a RIA / wealth management firm in Ohio
• Sell an insurance agency in Ohio
• Sell a managed IT / MSP business in Ohio
• Sell a Commercial HVAC business in Ohio
• Sell Your Ohio Business (state hub with all verticals)

Veterinary practice sales in other states

• Texas
• California
• Florida

Ohio veterinary practice sale: frequently asked questions